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Study Acronym Study Name Country Study Design N Cases
Age (mean, 
years)
N Controls
Age (mean, 
years)
ABCFS Australian Breast Cancer Family Study Australia Population-based case-control study 790 39.5 551 41.9
ABCS Amsterdam Breast Cancer Study Netherlands Hospital-based consecutive cases; population-based 
controls
1,941 42.8 1,557 47.3
BBCC Bavarian Breast Cancer Cases and Controls Germany Hospital based cases; population based controls 554 60.7 458 57.1
BBCS British Breast Cancer Study UK Cancer registry and National Cancer Research network 
(NCRN) based cases; population based controls
1,445 52.7 1,329 45.1
BIGGS Breast Cancer in Galway Genetic Study Ireland Hospital based cases; population based controls 779 53.3 49 65.6
BSUCH Breast Cancer Study of the University of 
Heidelberg
Germany Hospital based cases; healthy blood donator controls 814 55.3 954 57.3
CECILE CECILE Breast Cancer Study France Population-based case-control study 900 54.4 999 54.7
CGPS Copenhagen General Population Study Denmark Population-based case-control study 2,811 61.8 4,534 58.2
CNIO-BCS Spanish National Cancer Centre Breast 
Cancer Study
Spain Case-control study 704 54.2 834 50.0
CTS California Teachers Study USA Prospective cohort study: nested case-control 51 62.9 44 55.6
ESTHER ESTHER Breast Cancer Study Germany Population-based case-control study 471 60.6 502 62.3
GC-HBOC German Consortium for Hereditary Breast & 
Ovarian Cancer
Germany Population-based familial case-control study 0 0.0 139 57.7
GENICA Gene Environment Interaction and Breast 
Cancer in Germany
Germany Population-based case-control study 465 57.0 427 57.3
HEBCS Helsinki Breast Cancer Study Finland Hospital-based case-control study + additional familial 
cases 
1,517 56.8 1,234 41.0
HMBCS Hannover-Minsk Breast Cancer Study Belarus Hospital based cases; population based controls 688 49.0 130 41.9
KBCP Kuopio Breast Cancer Project Finland Population-based prospective clinical cohort 411 58.9 251 52.9
LMBC Leuven Multidisciplinary Breast Centre Belgium Hospital-based case-control study 2,522 56.6 1,386 44.0
MARIE Mammary Carcinoma Risk Factor 
Investigation
Germany Population-based case-control study 1,656 62.3 1,778 61.8
Table S1 Description of 37 Breast Cancer Association Consortium studies included in this analysis.
Study Acronym Study Name Country Study Design N Cases
Age (mean, 
years)
N Controls
Age (mean, 
years)
MBCSG Milan Breast Cancer Study Group Italy Clinic-based recruitment of familial/early onset breast 
cancer patients (cases);  population-based controls
189 42.0 400 42.3
MCBCS Mayo Clinic Breast Cancer Study USA Hospital-based case-control study 1,546 57.0 1,931 56.6
MCCS Melbourne Collaborative Cohort Study Australia Population-based prospective cohort study 614 60.8 511 56.3
MEC Multi-ethnic Cohort USA Prospective cohort study: nested case-control study 703 66.4 741 59.8
MTLGEBCS Montreal Gene-Environment Breast Cancer 
Study
Canada Population-based case-control study 489 61.8 436 61.6
NBCS Norwegian Breast Cancer Study Norway Hospital-based case-control study 828 60.1 214 51.0
NBHS Nashville Breast Health Study USA Population-based case-control study 125 52.6 118 52.6
OBCS Oulu Breast Cancer Study Finland Hospital-based case-control study 500 57.5 414 42.4
OFBCR Ontario Familial Breast Cancer Registry Canada Population-based familial case-control study 1,157 53.0 511 51.9
PBCS NCI Polish Breast Cancer Study Poland Population-based case-control study 519 56.3 424 56.3
SASBAC Singapore and Sweden Breast Cancer Study Sweden Population-based case-control study 1,163 63.0 1,378 63.3
SBCS Sheffield Breast Cancer Study UK Hospital-based case-control study 751 59.5 848 57.5
SEARCH Study of Epidemiology and Risk factors in 
Cancer Heredity
UK Population-based case-control study 9,095 54.4 8,064 57.8
SKKDKFZS Städtisches Klinikum Karlsruhe Deutsches 
Krebsforschungszentrum Study
Germany Hospital-based breast cancer cohort 134 58.9 29 60.7
SZBCS IHCC-Szczecin Breast Cancer Study Poland Hospital based case-control study 303 55.7 315 57.4
TNBCC Triple Negative Breast Cancer Study USA and Greece Hospital-based case-control study 499 52.9 152 55.4
UKBGS UK Breakthrough Generations Study UK Prospective cohort study: nested case-control study of 
women who had had breast cancer prior to entry into the 
cohort
413 56.3 470 54.2
kConFab/AOCS Kathleen Cuningham Foundation 
Consortium for research into Familial Breast 
Cancer/Australian Ovarian Cancer Study
Australia and New 
Zeland
Clinic-based recruitment of familial breast cancer patients 
(cases);  population-based case-control study of ovarian 
cancer (controls only)
410 45.7 897 57.8
pKARMA Karolinska Mammography Project for Risk 
Prediction of Breast Cancer - prevalent 
cases
Sweden Case-control study 4,553 58.1 5,568 53.4
